| Product Description |
Code Info |
Classification |
Reason for Recall |
Product Quantity |
Recall Number |
| LLOYD Thyro-Tabs (Levothyroxine sodium tablets, USP), 0.2 mg., packaged in 120-ct. (NDC 11789-252-10) and 1,000-ct. bottles (NDC 11789-252-20), RX, LLOYD, Inc., Shenandoah, IA.. |
KA16611, exp. SEP 2012 |
Class III |
Product lot KA16611 did not meet finished product release specifications |
2,535/120-ct. and 648/1,000-ct. bottles |
V-112-2013 |
| Levothyroxine sodium tablets, USP, 0.3 mg., RX, packaged under the following labels:
(1) LLOYD Thyro-Tabs, packaged in 120-ct. (NDC 11789-253-10) and 1,000-ct. bottles (NDC 11789-253-20), LLOYD, Inc., Shenandoah, IA;
(2) Butler Schein Animal Health Thyroxine L, packaged in 180-ct. (NDC 11695-4463-1) and 1,000-ct. bottles (NDC 11695-4463-2), Distributed Exclusively by Butler Schein Animal Health, Dublin, OH;
(3) Phoenix Thyrozine 0.3 mg., packaged in 180-ct. (NDC 57319-333-31) and 1,000-ct. bottles (NDC 57319-333-16), Manufactured for Clipper Distributing Company, LLC, St. Joseph, MO;
(4) VEDCO Thyrosyn .3 mg Tablets, packaged in 180-ct. (NDC 50989-201-86) and 1,000-ct. bottles (NDC 50989-201-53), Manufactured by LLOYD, Inc., Shenandoah, IA, Distributed by VEDCO, INC., St. Joseph, MO. |
Thyro-Tabs - KB15711, exp. SEP 2012;
Thyroxine L - KB13611 and KB13611A, exp. AUG 2012; and KB15711 and KB15711A, exp. SEP 2012;
Thyrozine - KB15711 and KB15711F, exp. SEP 2012; and KB13611 and KB13611A, Exp. AUG 2012; and
Thyrosyn - KB13611 and KB13611A, exp. AUG 2012. |
Class III |
Product did not meet in-process specification |
1,210/120-ct., 1,941/180-ct., and 3,176/1,000-ct. bottles |
V-113-2013 |
| Levothyroxine sodium tablets, USP, 0.7 mg.,RX, packaged under the following labels:
(1) LLOYD Thyro-Tabs, packaged in 120-ct. (NDC 11789-257-10), and 1,000-ct. bottles (NDC 11789-257-20), LLOYD, Inc., Shenandoah, IA;
(2) Butler Schein Animal Health Thyroxine L, packaged in 180-ct. (NDC 11695-4463-1) and 1,000-ct. bottles (NDC 11695-4463-2) , Distributed Exclusively by Butler Schein Animal Health, Dublin, OH;
(3) Phoenix Thyrozine 0.7 mg, packaged in 180-ct. (NDC 57319-337-31) and 1,000-ct. bottles (NDC 57319-337-16), Manufactured for Clipper distributing Company, LLC, St. Joseph, MO;
(4) VEDCO Thyrosyn .7 mg Tablets, packaged in 180-ct. bottles (NDC 50989-283-86), Manufactured by LLOYD, Inc., Shenandoah, IA, Distributed By VEDCO, INC., St. Joseph, MO. |
Thyro-Tabs - Lot KB18011, exp. OCT 2012;
Thyroxine L - Lot KB18011 and KB18011A, exp. OCT 2012;
Thyrozine - Lot KB18011, KB18011F, and KB18011FA, exp. OCT 2012; and
Thyrosyn - Lot KB18011 and KB18011A, exp. OCT 2012. |
Class III |
Product did not meet in-process specification |
2,300/120-ct., 1,517/180-ct., and 1,286/1,000-ct. bottles |
V-114-2013 |
| Levothyroxine sodium tablets, USP, 0.8 mg., packaged in 1,000-ct. bottles, RX, under the following private labels:
(1) Butler Schein Animal Health Thyroxine L, NDC 11695-4468-2, Distributed Exclusively by Butler Schein Animal Health, Dublin. OH; and
(2) VEDCO Thyrosyn .8 mg Tablets, NDC 50989-204-53, Manufactured by LLOYD, Inc., Shenandoah, IA, Distributed by VEDCO, INC., St. Joseph, MO. |
Thyroxine L - KD11711, exp. AUG 2012; and
Thyrosyn - KD11711 and KD11711A, exp. AUG 2012. |
Class III |
Product did not meet in-process specification |
1,891/1,000-ct. bottles |
V-115-2013 |
| LLOYD Thyro-Tabs (Levothyroxine sodium tablets, USP), 1.0 mg., packaged in 120-ct. (NDC 11789-268-10) and 1,000-ct. bottles (NDC 11789-268-20), RX. The firm name on the label is LLOYD, Inc., Shenandoah, IA. |
Lot KB17311, exp. OCT 2012 |
Class III |
Product did not meet in-process specification |
4,232/120-ct. and 811/1,000-ct. bottles |
V-116-2013 |